Executive Summary: Treatment of Osteoporosis and Osteoarthritis in the Oldest Old

Nicola Veronese; Nicholas C Harvey; René Rizzoli; Nicholas R Fuggle; Jean-Yves Reginster; ESCEO Working Group on the Management of Musculoskeletal Health in the Oldest Old Individuals

doi:10.1007/s40266-025-01184-7

Executive Summary: Treatment of Osteoporosis and Osteoarthritis in the Oldest Old

Drugs Aging. 2025 Mar;42(3):179-181. doi: 10.1007/s40266-025-01184-7. Epub 2025 Feb 24.

Authors

Nicola Veronese¹, Nicholas C Harvey^{2

3}, René Rizzoli⁴, Nicholas R Fuggle², Jean-Yves Reginster⁵; ESCEO Working Group on the Management of Musculoskeletal Health in the Oldest Old Individuals

Collaborators

ESCEO Working Group on the Management of Musculoskeletal Health in the Oldest Old Individuals:
Nicholas R Fuggle, Andrea Laslop, Nasser Al-Daghri, Majed Alokail, Ewa Balkowiec-Iskra, Charlotte Beaudart, Olivier Bruyère, Angie Botto-van Bemden, Nansa Burlet, Etienne Cavalier, Francesca Cerreta, Manju Chandran, Antonio Cherubini, Mario Miguel Coelho da Silva Rosa, Philip Conaghan, Bernard Cortet, Alfonso Cruz Jentoft, Elizabeth M Curtis, Patrizia D'Amelio, Bess Dawson-Hughes, Elaine M Dennison, Mickaël Hiligsmann, Jean-Marc Kaufman, Stefania Maggi, Radmila Matijevic, Eugene McCloskey, Daniel Messina, Daniel Pinto, Maria Concepcion Prieto Yerro, Régis Pierre Radermecker, Yves Rolland, Carla Torre, John A Kanis, Cyrus Cooper, Nicholas C Harvey

Affiliations

¹ Saint Camillus International, University of Health Sciences, Rome, Italy. nicola.veronese@unicamillus.org.
² MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
³ NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital NHS Foundation Trust, Southampton, United Kingdom.
⁴ Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
⁵ Protein Research Chair, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.

PMID: 39992619
DOI: 10.1007/s40266-025-01184-7

Abstract

This is the executive summary of a work by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) (Nicholas Fuggle et al. in Drugs, 2024).

MeSH terms

Aged, 80 and over
Bone Density Conservation Agents* / therapeutic use
Humans
Osteoarthritis* / drug therapy
Osteoporosis* / drug therapy

Substances

Bone Density Conservation Agents